NYU Grossman School of Medicine’s two-year Endocrinology, Diabetes, and Metabolism Fellowship offers experience in patient care, research, and teaching, as well as opportunities to delve deeply into all aspects of this subspecialty. Along with comprehensive and unequaled exposure to metabolic and endocrine conditions, our graduates learn to ask questions about the causes of disease as well as its treatments. This fellowship is accredited by the Accreditation Council for Graduate Medical Education (ACGME).

Fellows in our program work with a patient population affected by a wide range of endocrine disorders. They provide inpatient consultative services at three sites: NYU Langone’s Tisch Hospital and Kimmel Pavilion; NYC Health + Hospitals/Bellevue, where we care for individuals from around the world; and the Manhattan campus of the VA NY Harbor Healthcare System, where house staff treat people who have general endocrine problems, male endocrinopathies, and endocrine consequences of traumatic brain injury, among other conditions. Our fellows also have opportunities to rotate through pediatric endocrine and diabetes clinics, a high-risk obstetrics clinic, and gynecology clinics.

Didactic courses in both basic and clinical subjects taught by expert physicians and scientists complement the clinical experience. Throughout the training experience, fellows also mentor and instruct medical students and residents.

Meet our faculty members in the Holman Division of Endocrinology, Diabetes, and Metabolism and learn more about their experience and research interests.

We accept three to five incoming fellows to our program each year. Learn more about our fellowship curriculum and learn how to apply.

Our Research Strengths

NYU Langone boasts one of the world’s strongest research programs in endocrinology. Among our research strengths are laboratory studies of diabetes and lipid metabolism and complications of obesity. Studies in the Diabetes Research Program include advanced glycation end products, aldose reductase, and the effect of diabetes on white blood cell function.

In addition, a number of investigators in the Division of General Internal Medicine and Clinical Innovation, the Division of Geriatric Medicine and Palliative Care, and the Department of Population Health run National Institutes of Health (NIH)–funded epidemiologic and implementation science projects in diabetes and obesity.

During the past five years, the division has received two American Heart Association Specialized Focused Research Network grants, one in obesity and another in cardiometabolic diseases with a focus on diabetes. Both grants also support research training fellowships. In addition, we share with the Leon H. Charney Division of Cardiology an NIH-funded fellowship programs in cardiometabolic disease.

Areas of Concentration for Fellows

Fellows in our program have opportunities to work with faculty and patients in the following areas of concentration.

Diabetes Concentration

In this concentration fellows receive training in continuous glucose monitoring and insulin pump therapies. Fellows have the opportunity to treat people who have type 1 or type 2 diabetes, gestational diabetes, or other forms of the disease, such as diabetes induced by steroid use or hyperalimentation. In addition to our three clinical sites, trainees also treat patients at the Center for Diabetes and Metabolic Health. Under the leadership of Lauren H. Golden, MD, the center works to make a multidisciplinary care team approach the standard in diabetes care. We also have a special interest in the development of continued glucose monitors to diagnose prediabetes and the use of implantable glucose monitors.

Additional faculty associated with the diabetes concentration include Michael Bergman, MD, at the Manhattan campus of the VA NY Harbor Healthcare System, as well as Roshney Jacob-Issac, MD, Akankasha Goyal, MD, and Susan Zweig, MD.

Lipids and Obesity Concentration

At two locations, fellows treat patients who have common and exotic disorders of lipoprotein metabolism. Ira J. Goldberg, MD treats patients who have hyperlipidemia and unusual dyslipidemias at the Center for Diabetes and Metabolic Health. Many of these patients also have type 2 diabetes or are referred for preventive cardiology. James A. Underberg, MD, directs a large lipoprotein disorders clinic at Bellevue.

Fellows also participate in a weekly clinical conference attended by physicians from the Center for the Prevention of Cardiovascular Disease.

Thyroid Concentration

The thyroid unit provides fellows with a rigorous and comprehensive educational experience across all aspects of thyroid disease. At our three clinical sites, fellows participate in the care of patients with hypothyroidism, hyperthyroidism, thyroid disease in pregnancy, thyroid nodules, and thyroid cancer under the supervision of expert physicians and physician scientists. The unit is led by Sumedha Chablani, MD, and includes Alexander R. Goldberg, MD, Sapir Nachum, MD, Julie A. Probst, MD, and Dr. Zweig.

Fellows have extensive opportunities to develop and refine technical proficiencies, including thyroid ultrasonography and fine needle aspiration biopsy of thyroid nodules across both inpatient and outpatient settings. Training occurs at NYC Health + Hospitals Bellevue and NYU Langone Ambulatory Care Center East 41st Street. The program is also among the first in the United States to employ radiofrequency ablation as a nonsurgical treatment option for select benign thyroid nodules causing compressive or cosmetic symptoms.

This rich clinical exposure is complemented by a highly interactive didactic curriculum that includes monthly cytopathology and nuclear medicine conferences. Fellows are additionally encouraged to present complex thyroid cancer cases at a multidisciplinary tumor board held bimonthly, attended by endocrinologists, endocrine surgeons, otolaryngologists, medical oncologists, radiation oncologists, radiologists, pathologists, and nuclear medicine physicians.

Fellows also have opportunities to engage in clinical research in thyroid disease, with a particular focus on thyroid nodules and thyroid cancer. Recent projects have examined molecular alterations relevant to the diagnosis and management of thyroid neoplasms and have resulted in abstracts presented at national meetings as well as first author publications in peer reviewed journals.

Bone Concentration

Fellows receive comprehensive training in the evaluation and management of osteoporosis and complex metabolic bone diseases, including Paget’s disease and osteomalacia. The concentration emphasizes diagnostic reasoning through systematic assessment of secondary causes of bone loss and hands on interpretation of dual-energy X-ray absorptiometry (DXA) scans. Fellows participate in a monthly osteoporosis case conference and work closely with radiology and rheumatology colleagues to integrate imaging, laboratory data, and clinical decision making. The program also offers emerging opportunities for clinical and translational research in bone health and skeletal metabolism, supporting fellows interested in academic careers or developing subspecialty expertise in metabolic bone disease.

Faculty associated with the bone concentration include Dr. Goldberg, Rachel Pessah-Pollack, MD, and Dr. Zweig.

Our Current Fellows

Our current fellows bring a range of experiences and expertise to our program.

First-Year Fellows

Kristen Carroll, MD
Karen Chen, MD
Magdalene Economou, MD
Margaret Ruddy, MD

Second-Year Fellows

Bushra Azom, MD
Amanda Bonano, MD
Julie Kim, MD
Ariel Li, MD

Contact Us

Dr. Probst is director of the Endocrinology, Diabetes, and Metabolism Fellowship; Karin A. Katz, MD, is associate director. For questions about the fellowship, please contact Ysa Wilson, program coordinator, at Ysa.Wilson@NYULangone.org or 212-263-8060.